SlidesetViral Hepatitis and Liver DiseaseWHO status report: Global response to the strategic framework- Yvan Hutin, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseSetting the stage - Key challenges in elimination- Jordan Feld, MD, MPHView Slideset
SlidesetViral Hepatitis and Liver DiseaseHow to measure your success; globally and locally- Yvan Hutin, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Myanmar- Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCPView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Brazil- Maria Cássia Jacintho Mendes Correa, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Denmark- Jeffrey Lazarus, PhD, MIH, MAView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Pakistan- Huma Qureshi, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Australia- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseReal-life experiences - bottlenecks & hurdles- Nigeria, sub-Saharan Africa- Olufunmilayo Lesi, MD, MBA, FMCP, FWACPView Slideset
SlidesetViral Hepatitis and Liver DiseasePrevention transmission strategies prior to infection - People who inject drugs- Diana Sylvestre, MDView Slideset
SlidesetViral Hepatitis and Liver DiseasePrevention transmission strategies prior to infection - Incarceration- Lara Strick, MD, MSView Slideset
SlidesetViral Hepatitis and Liver DiseasePrevention transmission strategies through strengthening the health system- Maia Butshashvili, MD, MS, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseMicro-elimination as a strategy to reach global elimination- Jeffrey Lazarus, PhD, MIH, MAView Slideset
SlidesetViral Hepatitis and Liver DiseaseMedicines Patent Pool’s approach to scale up access to HIV and HCV treatment- Esteban BurroneView Slideset
